Your browser doesn't support javascript.
loading
Triplet therapy with afatinib, cetuximab, and bevacizumab induces deep remission in lung cancer cells harboring EGFR T790M in vivo.
Kudo, Kenichiro; Ohashi, Kadoaki; Makimoto, Go; Higo, Hisao; Kato, Yuka; Kayatani, Hiroe; Kurata, Yasuko; Takami, Yoichiro; Minami, Daisuke; Ninomiya, Takashi; Kubo, Toshio; Ichihara, Eiki; Sato, Akiko; Hotta, Katsuyuki; Yoshino, Tadashi; Tanimoto, Mitsune; Kiura, Katsuyuki.
Afiliación
  • Kudo K; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
  • Ohashi K; Department of Respiratory Medicine, Okayama University Hospital, Japan.
  • Makimoto G; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
  • Higo H; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
  • Kato Y; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
  • Kayatani H; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
  • Kurata Y; Department of Pharmacy, Okayama University Hospital, Japan.
  • Takami Y; Pharmaceutical Care and Health Sciences, School of Pharmacy, Shujitsu University, Okayama, Japan.
  • Minami D; Department of Respiratory Medicine, Okayama University Hospital, Japan.
  • Ninomiya T; Department of Respiratory Medicine, Okayama University Hospital, Japan.
  • Kubo T; Center for Clinical Oncology, Okayama University Hospital, Japan.
  • Ichihara E; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
  • Sato A; Department of Respiratory Medicine, Okayama University Hospital, Japan.
  • Hotta K; Center for Innovative Clinical Medicine, Okayama University Hospital, Japan.
  • Yoshino T; Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
  • Tanimoto M; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
  • Kiura K; Department of Respiratory Medicine, Okayama University Hospital, Japan.
Mol Oncol ; 11(6): 670-681, 2017 06.
Article en En | MEDLINE | ID: mdl-28388009
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quinazolinas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores ErbB / Bevacizumab / Cetuximab / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quinazolinas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores ErbB / Bevacizumab / Cetuximab / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos